Study

SAFETY AND EFFICACY OF LUMIONSKIN IN MANAGING ACNE THROUGH ASSESSMENT OF ITS LESIONS AND ERYTHEMA

Dendy E. Engelman, M.D., Mussarrat Hussain M.D.
Manhattan Dermatology and Cosmetic Surgery, New York, NY



BACKGROUND

Acne Vulgaris is a common dermatological condition, which most often affect face, upper chest, upper back and shoulder. Alone in United States, it affects millions of adolescent boys and girls and even adult men and women are not spared.

In many cases if left untreated, acne can result in physical sequelae and psychological problems that significantly impact the subject’s quality of life.

A choice of good number of acne therapies are available to the doctors and patients  but many therapies can cause considerable side effects, have contraindications, and become less effective with repeated usage (eg, due to antibiotic resistance). So safer, more convenient, and more efficacious treatment options are needed. In particular, options with less frequent treatments would be expected to enhance simplifying acne treatment regimens.

 

OBJECTIVE

The objective of this study is to evaluate the efficacy and safety of the Investigational Product (a novel topical mist/serum) on the facial skin to the baseline of the individuals with moderate to severe acne vulgaris.

 

FINAL REPORT:

Subjects used the Investigational Product (IP), three times a day for 12 weeks.  According to the final report, investigators and subjects noted improvement in Acne Vulgaris and erythema. Treatment is being well tolerated.

Week 1

Week 2

Week 1

Week 2